These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22123025)
21. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial. Priebe S; Bremner SA; Lauber C; Henderson C; Burns T Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868 [TBL] [Abstract][Full Text] [Related]
22. Treatment patterns and costs in patients with generalised anxiety disorder: one-year retrospective analysis of data from national registers in Sweden. Sandelin R; Kowalski J; Ahnemark E; Allgulander C Eur Psychiatry; 2013 Feb; 28(2):125-33. PubMed ID: 22542328 [TBL] [Abstract][Full Text] [Related]
23. Cost of depression in Europe. Sobocki P; Jönsson B; Angst J; Rehnberg C J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486 [TBL] [Abstract][Full Text] [Related]
24. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care. Counterweight Project Team J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765 [TBL] [Abstract][Full Text] [Related]
25. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence. Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812 [TBL] [Abstract][Full Text] [Related]
26. Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence. Dalén J; Svedbom A; Black CM; Lyu R; Ding Q; Sajjan S; Sazonov V; Kachroo S Rheumatol Int; 2016 Jul; 36(7):987-95. PubMed ID: 26780533 [TBL] [Abstract][Full Text] [Related]
27. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study. Sidorchuk A; Isomura K; Molero Y; Hellner C; Lichtenstein P; Chang Z; Franck J; Fernández de la Cruz L; Mataix-Cols D PLoS Med; 2018 Aug; 15(8):e1002635. PubMed ID: 30086134 [TBL] [Abstract][Full Text] [Related]
28. Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins. McRae I; van Gool K; Hall J; Yen L Appl Health Econ Health Policy; 2017 Oct; 15(5):625-634. PubMed ID: 28660496 [TBL] [Abstract][Full Text] [Related]
29. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris. Tan X; Al-Dabagh A; Davis SA; Lin HC; Balkrishnan R; Chang J; Feldman SR Am J Clin Dermatol; 2013 Jun; 14(3):243-51. PubMed ID: 23572294 [TBL] [Abstract][Full Text] [Related]
30. A pharmacoeconomic analysis of compliance gains on antipsychotic medications. Damen J; Thuresson PO; Heeg B; Lothgren M Appl Health Econ Health Policy; 2008; 6(4):189-97. PubMed ID: 19382819 [TBL] [Abstract][Full Text] [Related]
32. Socio-economic burden of patients with a diagnosis related to chronic pain--register data of 840,000 Swedish patients. Gustavsson A; Bjorkman J; Ljungcrantz C; Rhodin A; Rivano-Fischer M; Sjolund KF; Mannheimer C Eur J Pain; 2012 Feb; 16(2):289-99. PubMed ID: 22323381 [TBL] [Abstract][Full Text] [Related]
33. A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project. Lesén E; Sandström TZ; Carlsten A; Jönsson AK; Mårdby AC; Sundell KA Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1073-9. PubMed ID: 21853505 [TBL] [Abstract][Full Text] [Related]
34. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany]. Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279 [TBL] [Abstract][Full Text] [Related]
35. Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study. Karlsson SA; Hero C; Eliasson B; Franzén S; Svensson AM; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Andersson Sundell K Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1220-1232. PubMed ID: 28799214 [TBL] [Abstract][Full Text] [Related]
36. Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study. Wigertz A; Ahlgren J; Holmqvist M; Fornander T; Adolfsson J; Lindman H; Bergkvist L; Lambe M Breast Cancer Res Treat; 2012 May; 133(1):367-73. PubMed ID: 22286315 [TBL] [Abstract][Full Text] [Related]
37. Full coverage for preventive medications after myocardial infarction. Choudhry NK; Avorn J; Glynn RJ; Antman EM; Schneeweiss S; Toscano M; Reisman L; Fernandes J; Spettell C; Lee JL; Levin R; Brennan T; Shrank WH; N Engl J Med; 2011 Dec; 365(22):2088-97. PubMed ID: 22080794 [TBL] [Abstract][Full Text] [Related]
38. Regional variation and adherence to guidelines for drug treatment of asthma. Arnlind MH; Wettermark B; Nokela M; Hjemdahl P; Rehnberg C; Jonsson EW Eur J Clin Pharmacol; 2010 Feb; 66(2):187-98. PubMed ID: 19826799 [TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain. Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A; Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869 [TBL] [Abstract][Full Text] [Related]
40. Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA). Landfeldt E; Ström O; Robbins S; Borgström F Osteoporos Int; 2012 Feb; 23(2):433-43. PubMed ID: 21286686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]